These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4885730)

  • 21. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 22. Thymic dysplasia ("Swiss agammaglobulinemia"). I. Graft versus host reaction following bone-marrow transfusion.
    Miller ME
    J Pediatr; 1967 May; 70(5):730-6. PubMed ID: 4164455
    [No Abstract]   [Full Text] [Related]  

  • 23. Thymosin, a thymic hormone influencing lymphoid cell immunological competence.
    White A; Goldstein AL
    Ciba Found Study Group; 1970; 36():3-23. PubMed ID: 4399435
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemiallogeneic bone marrow transplantaton in a child with severe combined immunodeficiency disease.
    Frank LY; Rothberg RM; Pachman LM; Coppleson LW; Larner BJ; Peterson RD
    J Pediatr; 1972 Mar; 80(3):441-9. PubMed ID: 4400714
    [No Abstract]   [Full Text] [Related]  

  • 25. [Congenital alymphocytosis. Transfusion of bone marrow at birth. Graft-versus-host reaction?].
    Hennequet A; Amiel JL; Schwarzenberg L; Lyon G; Watchi JM; Cloup M; Allaneau C; Marie J
    Ann Pediatr (Paris); 1968 Nov; 15(11):706-15. PubMed ID: 4889504
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymic alymphoplasia with XX-XY lymphoid chimerism secondary to probable maternal-fetal transfusion.
    Githens JH; Muschenheim F; Fulginiti VA; Robinson A; Kay HE
    J Pediatr; 1969 Jul; 75(1):87-94. PubMed ID: 4182952
    [No Abstract]   [Full Text] [Related]  

  • 27. Incomplete restoration of the bursa-dependent immune system after transplantation of allogeneic stem cells into immunodeficient chicks.
    Toivanen P; Toivanen A; Sorvari T
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):957-61. PubMed ID: 4150769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of patients with primary immune deficiency syndromes.
    Wells JV; Fudenberg HH
    Aust N Z J Med; 1974 Aug; 4(4):396-411. PubMed ID: 4138460
    [No Abstract]   [Full Text] [Related]  

  • 29. The thymus in immune deficiency.
    Kay HE
    Proc R Soc Med; 1968 Sep; 61(9):889-90. PubMed ID: 4878257
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of severe combined immunodeficiency by a small number of pretreated nonmatched marrow cells.
    Huang SW; Ammann AJ; Levy RL; Hong R; Bach FH
    Transplantation; 1973 Jan; 15(1):174-6. PubMed ID: 4145722
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bone marrow transplantation].
    Fölsch E
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1394-8. PubMed ID: 4403441
    [No Abstract]   [Full Text] [Related]  

  • 32. Reconstitution of cellular immune function in a child with thymic aplasia by foetal thymus grafting.
    Jose DG; Barnes G; Rossiter EJ; Myers NA; Fitzgerald MG
    Aust N Z J Med; 1974 Jun; 4(3):267-73. PubMed ID: 4548646
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

  • 35. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 36. Roentgenographic findings following bone-marrow transplantations in patients with combined immunodeficiency disease.
    L'Heureux PR; Biggar WD; Park BH; Good RA
    Radiology; 1974 Jan; 110(1):163-8. PubMed ID: 4586337
    [No Abstract]   [Full Text] [Related]  

  • 37. Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion.
    Niethammer D; Goldmann SF; Flad HD; Bienzle U; Dieterle U; Haas RJ; Heymer B; Meigel W; Belohradsky BH; Kleihauer E
    Clin Immunol Immunopathol; 1981 Mar; 18(3):387-401. PubMed ID: 7018767
    [No Abstract]   [Full Text] [Related]  

  • 38. Y chromatin as indicator of chimaerism following bone marrow transplantation in severe combined immunodeficiency.
    Nielsen H; Koch C; Müller-Berat N; Philip J
    Scand J Immunol; 1973; 2(4):327-31. PubMed ID: 4588903
    [No Abstract]   [Full Text] [Related]  

  • 39. Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.
    Hansen JA; O'Reilly RJ; Good RA; Dupont B
    Transplant Proc; 1976 Dec; 8(4):581-9. PubMed ID: 63170
    [No Abstract]   [Full Text] [Related]  

  • 40. Depletion of complement during graft-versus-host reaction in a severe combined immunodeficiency patient after receiving a mismatched marrow transplant.
    Ballow M; Day NK; Good RA
    Transplantation; 1973 Oct; 16(4):380-2. PubMed ID: 4147640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.